237
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation

, , , , , , , & show all
Pages 272-287 | Received 12 Nov 2013, Accepted 13 Mar 2014, Published online: 02 May 2014

REFERENCES

  • Stevenson CS, Docx C, Webster R, Battram C, Hynx D, Giddings J, Cooper PR, Chakravarty P, Rahman I, Marwick JA, Kirkham PA, Charman C, Richardson DL, Nirmala NR, Whittaker P, Butler K. Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1183–L1193.
  • Marwick JA, Caramori G, Stevenson CC, Casolari P, Jazrawi E, Barnes PJ, Ito K, Adcock IM, Kirkham PA, Papi A: Inhibition of PI3K {delta} restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med. 2009;179:542–548.
  • O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK: Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T-lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155:852–857.
  • Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM: CD8 +T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822–826.
  • Vlahos R, Bozinovski S, Jones JE, Powell J, Gras J, Lilja A, Hansen MJ, Gualano RC, Irving L, Anderson GP: Differential protease, innate immunity and NFkB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol. 2006;290:L931–L945.
  • Groneberg DA, Chung KF: Models of chronic obstructive pulmonary disease. Respir Res. 2004;5:18.
  • Eurell JA, Frappier BL: Dellmann's Textbook of Veterinary Histology. 6th ed. Ames: Blackwell Publishing; 2006.
  • Leith DE: Comparative mammalian respiratory mechanics. Physiologist. 1976;19:485–510.
  • Cunningham JG, Klein BG: Textbook of Veterinary Physiology. 4th ed. Philadelphia: Saunders; 2007.
  • Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken MP, Beeh KM, Rabe KF, Fabbri LM, POET-COPD Investigators: Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med. 2011; 364:1093–1103.
  • Wollin L, Pieper MP: Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther. 2010;23:345–354.
  • Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker R, Gosens R, Maarsingh H, Zaagsma J, Meurs H: Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J. 2011;38:789–796.
  • Zheng H, Liu Y, Huang T, Fang Z, Li G, He S: Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett. 2009;189:225–234.
  • Ettinger SJ, Feldman EC: Textbook of Veterinary Internal Medicine. 7th ed. St. Louis, MO: Saunders; 2010.
  • Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF: Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J. 1998;12:380–386.
  • Kolahian S, Asadi F, Nassiri SM: Airway inflammatory events in diabetic antigen sensitized guinea pigs. Eur J Pharmacol. 2011;659:252–258
  • Satho K: Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin Chem Acta. 1978;90:37–43.
  • Buege JA, Aust SD: Microsomal lipid peroxidation. Meth Enzymol. 1978;52:302–310.
  • Benzie IFF, Strain JJ: Ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem. 1996;239:70–76.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265–275.
  • Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L, Cassino C, Kesten S: Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med. 2005;143:317–326.
  • Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359:1543–1554.
  • Gan WQ, Man SF, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574–580.
  • Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 2007;87:1047–1082.
  • D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA: Time course of cigarette smoke-induced pulmonary inflammation in mice. Eur Respir J. 2005;26:204–213.
  • Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM: Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:1773–1777.
  • Keatings VM, Collins PD, Scott DM, Barnes PJ: Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Resp Crit Care Med. 1996;153:530–534.
  • Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF: Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers: regulation by interleukin-10. Am J Respir Crit Care Med. 2000;16:1355–1360.
  • Kuschner WG, D'Alessandro A, Wong H, Blanc PD: Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9:1989–1994.
  • Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI: Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997;155:1770–1776.
  • Dubar V, Gosset P, Aerts C, Voisin C, Wallaert B, Tonnel AB: In vitro acute effects of tobacco smoke on tumor necrosis factor-a and interleukin-6 production by alveolar macrophages. Exp Lung Res. 1993;19:345–349.
  • Gosens R, Rieks D, Meurs H, Ninaber DK, Rabe KF, Nanninga J, Kolahian S, Halayko AJ, Hiemstra PS, Zuyderduyn S: Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J. 2009;34:1436–1443.
  • Oenema T, Kolahian S, Nanninga J, Rieks D, Hiemstra PS, Zuyderduyn S, Halayko AJ, Meurs H, Gosens R: Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle. Respir Res. 2010;11:130.
  • Kolahian S, Gosens R: Cholinergic regulation of airway inflammation and remodelling. J Allergy. 2012; doi:10.1155/2012/681258.
  • Buhling F, Lieder N, Kuhlman UC, Waldburg N, Welte T: Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro. Respir Med. 2007;101:2386–2394.
  • Wright JL, Churg A: Animal models of COPD: barriers, successes, and challenges. Pulm Pharmacol Ther. 2008;21:696–698.
  • Shapiro SD: Animal models for chronic obstructive pulmonary disease age of Klotho and Marlboro mice. Am J Respir Cell Mol Biol. 2000;22:4–7.
  • Hayashi M, Sorenberger GC, Huber GL: Morphometric analyses of tracheal gland secretion and hypertrophy in male and female rats after experimental exposure to tobacco smoke. Am Rev Respir Dis. 1979;119:67–73.
  • Rogers F: Motor control of airway goblet cells and glands. Respir Physiol. 2001;125:129–144.
  • Joo NS, Saenz Y, Krouse ME, Wine JJ: Mucus secretion from single submucosal glands of pig. Stimulation by carbachol and vasoactive intestinal peptide. J Biol Chem. 2002;277:28167–28175.
  • Szilasi M, Dolinary T, Nemes Z, Strause J: Pathology of chronic obstractive pulmonary disease. Pathol Oncol Res. 2006;12:52–60.
  • Arai N, Kondo M, Izumo T, Tamaoki J, Nagai A: Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Respir J. 2010;35:1164–1171.
  • Orhan H, Evelo CTA, Sahin G: Erythrocyte antioxidant defense response against cigarette smoking in humans—the gutathione S-transferase vulnerability. J Biochem Mol Toxicol. 2005;19:226–233.
  • Rahman I, MacNee W: Role of oxidants/antioxidants in smoking-induced airways diseases. Free Rad Biol Med. 1996;21:669–81.
  • Rahman I: The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med. 2005;4:175–200.
  • Barnes PJ, Adcock IM, Ito K: Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J. 2005;25:552–563.
  • McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD: Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med. 1994;150:696–703.
  • Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A: Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015–1022.
  • Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS: Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res. 2002;3:22–30.
  • Anto RJ, Mukhopadhyay A, Shishodia S, Gairola CG, Aggarwal BB: Cigarette smoke condensate activates nuclear transcription factor kB through phosphorylation and degradation of IkB-a: correlation with induction of cyclooxygenase-2. Carcinogenesis. 2002;23:1511–1518.
  • Heffner JE, Repine JE: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis. 1989;140:531–554.
  • Churg A, Cosio M, Wright JL: Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am J Physiol Lung Cell Mol Physiol. 2008;294:L612–L631.
  • Goco RV, Kress MB, Brantigan OC: comparison of mucus glands in the tracheobronchial tree of man and animals. Ann NY Acad Sci. 1963;106:555–571.
  • Widdicombe JH, Chen LL, Sporer H, Choi HK, Pecson IS, Bastacky SJ: Distribution of tracheal and laryngeal mucous glands in some rodents and the rabbit. J Anat. 2001;198:207–221.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.